FlightPath (Drug Discovery) Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$8.06M
- Investors
-
8
FlightPath (Drug Discovery) General Information
Description
Developer of antibiotic therapies designed to treat pathogen-driven diseases. The company's therapies kill co-infecting bacteria in Lyme disease to limit microbiome damage and treat multiple pathogenic bacteria in both the oral and gut microbiomes, enabling patients to get a new treatment to eradicate rare infectious diseases.
Contact Information
Website
www.flightpath.bioCorporate Office
- 2600 Tenth Street
- Suite 435
- Berkeley, CA 94710
- United States
Corporate Office
- 2600 Tenth Street
- Suite 435
- Berkeley, CA 94710
- United States
FlightPath (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 23-Oct-2024 | $8.06M | Completed | Pre-Clinical Trials | ||
| 2. Early Stage VC (Series A) | 16-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 1. Accelerator/Incubator | 08-Feb-2021 | $100K | $100K | Completed | Pre-Clinical Trials |
FlightPath (Drug Discovery) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | 125,512 | $0.000010 | 6% | $0.72 | $0.72 | 1x | $0.72 | 0.7% |
| Series A-2 | 2,720,246 | $0.000010 | 6% | $0.94 | $0.94 | 1x | $0.94 | 15.26% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
FlightPath (Drug Discovery) Comparisons
Industry
Financing
Details
FlightPath (Drug Discovery) Competitors (2)
One of FlightPath (Drug Discovery)’s 2 competitors is Siolta Therapeutics, a Venture Capital-Backed company based in San Carlos, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Siolta Therapeutics | Venture Capital-Backed | San Carlos, CA | ||||
| Seres Therapeutics | Formerly VC-backed | Cambridge, MA |
FlightPath (Drug Discovery) Patents
FlightPath (Drug Discovery) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025090445-A1 | Hygromycin a for treatment of diseases and infections | Inactive | 23-Oct-2023 | ||
| WO-2025090508-A1 | Hygromycin a for treatment of oral diseases and infections | Inactive | 23-Oct-2023 | ||
| WO-2025090508-A9 | Hygromycin a for treatment of oral diseases and infections | Inactive | 23-Oct-2023 | ||
| AU-2022353095-A1 | Hygromycin a for treatment of diseases and infections | Inactive | 24-Sep-2021 | ||
| CA-3232874-A1 | Hygromycin a for treatment of diseases and infections | Pending | 24-Sep-2021 | A61K31/7048 |
FlightPath (Drug Discovery) Signals
FlightPath (Drug Discovery) Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ann Arbor SPARK | Accelerator/Incubator | Minority | ||
| Invest Detroit Ventures | Corporate Venture Capital | Minority | ||
| Michigan Rise | Venture Capital | Minority | ||
| Northern Michigan Angels | Angel Group | Minority | ||
| Red Cedar Ventures | Venture Capital | Minority |
FlightPath (Drug Discovery) FAQs
-
When was FlightPath (Drug Discovery) founded?
FlightPath (Drug Discovery) was founded in 2019.
-
Where is FlightPath (Drug Discovery) headquartered?
FlightPath (Drug Discovery) is headquartered in Berkeley, CA.
-
What is the size of FlightPath (Drug Discovery)?
FlightPath (Drug Discovery) has 4 total employees.
-
What industry is FlightPath (Drug Discovery) in?
FlightPath (Drug Discovery)’s primary industry is Drug Discovery.
-
Is FlightPath (Drug Discovery) a private or public company?
FlightPath (Drug Discovery) is a Private company.
-
What is the current valuation of FlightPath (Drug Discovery)?
The current valuation of FlightPath (Drug Discovery) is .
-
What is FlightPath (Drug Discovery)’s current revenue?
The current revenue for FlightPath (Drug Discovery) is .
-
How much funding has FlightPath (Drug Discovery) raised over time?
FlightPath (Drug Discovery) has raised $9.7M.
-
Who are FlightPath (Drug Discovery)’s investors?
Ann Arbor SPARK, Invest Detroit Ventures, Michigan Rise, Northern Michigan Angels, and Red Cedar Ventures are 5 of 8 investors who have invested in FlightPath (Drug Discovery).
-
Who are FlightPath (Drug Discovery)’s competitors?
Siolta Therapeutics and Seres Therapeutics are competitors of FlightPath (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process